Sale!

NSDHL Gene CHILD Syndrome Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The NSDHL Gene CHILD Syndrome Genetic Test is a specialized diagnostic tool designed to identify mutations in the NSDHL gene, which are associated with CHILD Syndrome (Congenital Hemidysplasia with Ichthyosiform erythroderma and Limb Defects). This rare genetic condition is characterized by distinctive skin abnormalities and limb defects affecting one side of the body. The test is crucial for accurate diagnosis, allowing for tailored management and care plans for affected individuals.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab. The laboratory employs advanced genetic sequencing techniques to meticulously analyze the NSDHL gene for any mutations that are indicative of CHILD Syndrome.

The cost of the NSDHL Gene CHILD Syndrome Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis required to ensure accurate results, providing essential information for affected families and their healthcare providers. By confirming a diagnosis, this test paves the way for supportive treatments and interventions, significantly impacting the quality of life for those diagnosed with CHILD Syndrome.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

NSDHL Gene CHILD syndrome Genetic Test

Welcome to DNA Labs UAE, where we offer the NSDHL Gene CHILD syndrome Genetic Test. This test is used to diagnose and identify mutations in the NSDHL gene associated with CHILD syndrome.

Test Components

The NSDHL Gene CHILD syndrome Genetic Test includes:

  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Test Price

The cost of the NSDHL Gene CHILD syndrome Genetic Test is 4400.0 AED.

Test Details

The NSDHL gene is responsible for encoding the enzyme 3beta-hydroxysteroid-delta-7-reductase, which plays a crucial role in the production of cholesterol and other sterols. Mutations in this gene can lead to a rare genetic disorder known as CHILD syndrome (Congenital Hemidysplasia with Ichthyosiform erythroderma and Limb Defects).

CHILD syndrome is characterized by the presence of unilateral skin lesions that are red and scaly, as well as limb abnormalities such as underdevelopment or absence of fingers, toes, or limbs. The severity of the symptoms can vary widely between individuals.

NGS (Next-Generation Sequencing) genetic testing can be used to identify mutations in the NSDHL gene associated with CHILD syndrome. This type of testing involves analyzing the entire gene sequence to identify any variations or abnormalities that may be causing the disorder.

Genetic testing can be helpful in confirming a diagnosis of CHILD syndrome, as well as providing information about the specific genetic mutation involved. This information can be used to guide treatment and management strategies, as well as to inform genetic counseling and family planning decisions.

Pre Test Information

Prior to undergoing the NSDHL Gene CHILD syndrome Genetic Test, it is important to provide the clinical history of the patient who is going for the test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with NSDHL Gene CHILD syndrome.

Test Name NSDHL Gene CHILD syndrome Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for NSDHL Gene CHILD syndrome NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with NSDHL Gene CHILD syndrome
Test Details

The NSDHL gene is responsible for encoding the enzyme 3beta-hydroxysteroid-delta-7-reductase, which plays a crucial role in the production of cholesterol and other sterols. Mutations in this gene can lead to a rare genetic disorder known as CHILD syndrome (Congenital Hemidysplasia with Ichthyosiform erythroderma and Limb Defects).

CHILD syndrome is characterized by the presence of unilateral skin lesions that are red and scaly, as well as limb abnormalities such as underdevelopment or absence of fingers, toes, or limbs. The severity of the symptoms can vary widely between individuals.

NGS (Next-Generation Sequencing) genetic testing can be used to identify mutations in the NSDHL gene associated with CHILD syndrome. This type of testing involves analyzing the entire gene sequence to identify any variations or abnormalities that may be causing the disorder.

Genetic testing can be helpful in confirming a diagnosis of CHILD syndrome, as well as providing information about the specific genetic mutation involved. This information can be used to guide treatment and management strategies, as well as to inform genetic counseling and family planning decisions.